Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Retinoblastoma

imatinib mesylate has been researched along with Retinoblastoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barsh, SR; Brennan, RC; Coppess, W; Flores-Otero, J; Garcia-Vargas, A; Goldsmith, ZK; Irvine, AS; Martinez-Ferrer, M; McEwen, MW; Morales-Tirado, VM; Ritter, MK; Wilson, MW; Yuan, K1
Antecka, E; Burnier, MN; Fernandes, BF; Rielo de Moura, L; Sanft, DM; Worme, MD; Zoroquiain, P1
Antecka, E; Burnier, MN; de Moura, LR; Di Cesare, S; Fernandes, BF; Marshall, JC1
Banerjee, D; Banerjee, S; Chandra, S; Sengupta, A1

Other Studies

4 other study(ies) available for imatinib mesylate and Retinoblastoma

ArticleYear
Targeting the Platelet-Derived Growth Factor-beta Stimulatory Circuitry to Control Retinoblastoma Seeds.
    Investigative ophthalmology & visual science, 2018, 09-04, Volume: 59, Issue:11

    Topics: Antineoplastic Agents; Blotting, Western; Cell Culture Techniques; Drug Delivery Systems; Enzyme-Linked Immunosorbent Assay; Eye Enucleation; Flow Cytometry; Humans; Imatinib Mesylate; Immunohistochemistry; Neoplasm Seeding; NF-kappa B; Polymerase Chain Reaction; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Receptor, Platelet-Derived Growth Factor beta; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Signal Transduction; Tumor Cells, Cultured; Vitreous Body

2018
Immunohistochemical Analysis of PDGFR-α, PDGFR-β and c-Abl in Retinoblastoma: Potential Therapeutic Targets.
    Ophthalmic research, 2016, Volume: 55, Issue:3

    Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Child, Preschool; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Infant; Male; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Retinal Neoplasms; Retinoblastoma

2016
The effect of imatinib mesylate on the proliferation, invasive ability, and radiosensitivity of retinoblastoma cell lines.
    Eye (London, England), 2013, Volume: 27, Issue:1

    Topics: Antineoplastic Agents; Benzamides; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Radiation; Humans; Imatinib Mesylate; Immunohistochemistry; Neoplasm Invasiveness; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Radiation Tolerance; Receptor, Platelet-Derived Growth Factor alpha; Retinal Neoplasms; Retinoblastoma

2013
Gene therapy for BCR-ABL+ human CML with dual phosphorylation resistant p27Kip1 and stable RNA interference using an EBV vector.
    The journal of gene medicine, 2006, Volume: 8, Issue:10

    Topics: Active Transport, Cell Nucleus; Apoptosis; Benzamides; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Fusion Proteins, bcr-abl; G1 Phase; Genes, Transgenic, Suicide; Genetic Engineering; Genetic Therapy; Genetic Vectors; Herpesvirus 4, Human; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Models, Biological; Phosphorylation; Piperazines; Point Mutation; Pyrimidines; Retinoblastoma; RNA Interference; RNA, Small Interfering; S Phase; Tumor Cells, Cultured

2006